Search Results
![Dr. Allison Rosenthal at LLS's Light The Night](/sites/default/files/styles/tiered_sponsor/public/2024-03/02%20Allison%20R%20LTN.jpg?itok=5S9jS_d8)
“People Just Didn’t Get It”: Treating Young Adults with Cancer
Think of spring break: warm sunny skies, a refreshing drink, and hopefully, a feeling of freedom.
![RBG](/sites/default/files/styles/tiered_sponsor/public/2021-03/gettyimages%20ruthbaderginsburg.jpg?itok=Z4oRCWJZ)
Statement on the Death of Supreme Court Justice and Trailblazer Ruth Bader Ginsburg
Photo by Nikki Khan/The Washington Post via Getty Images
Here at The Leukemia & Lymphoma Society (LLS), we are devastated to learn of the passing of Associate Justice Ruth Bader Ginsburg from complications of metastatic pancreatic cancer. As the global leader in the fight against blood cancer, we stand with the cancer community – and all Americans – in mourning this trailblazer whose contributions to public health and equality will be felt by generations to come.
Childhood and Adolescent Blood Cancer Facts and Statistics
Childhood and Adolescent Blood Cancers- An estimated 54,817 children and adolescents younger than 20 years in the US are living with or in remission from leukemia, lymphoma, myeloma, myelodysplastic syndromes (MDS) or myeloproliferative neoplasms (MPNs).
- Leukemia is the most common cancer diagnosed in children and adolescents younger than 20 years and accounts for 25.1 percent of all cancer cases in this age-group.
- From 2015 to 2019, the most recent 5 years for which data are available, leukemia and lymphoma accounted for 37.9 percent of all cancer types in childr
Supporting development of RNA-targeting molecules for blood cancers
In June 2023, LLS made an equity investment in Rgenta Therapeutics to "Support development of RNA-targeting molecules for blood cancers." Rgenta Therapeutics is developing a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology and neurological disorders. Rgenta has a proprietary platform to mine the massive genomics data to identify targetable RNA processing events and to design small-molecule glues to modulate the interactions among the spliceosome, regulatory proteins, and RNAs. Choosing a Blood Cancer Specialist or a Treatment Center
Taking an active role in making decisions regarding your treatment can have a positive effect on your health and quality of life. One of your first choices as an active participant in your care is to either select a specialist to manage your treatment or to choose a treatment center.
You may be seeking a blood cancer specialist or a treatment center because you:
![Volunteers making an impact together](/sites/default/files/styles/tiered_sponsor/public/2021-04/volunteerimage-1199705899%20%281%29_0.jpg?itok=K4zXCcTz)
Because You Volunteer, Your Impact Creates a Ripple Effect
When you commit time and talent to a nonprofit’s mission – no matter how you choose to get involved – you become a volunteer, and the impact of your efforts runs far deeper than the specific project or task you work on. For example, volunteers don’t always realize that the hours they spent stocking shelves meant hundreds of families would have food for two weeks. Or that the time spent fundraising not only raised critical mission dollars but also added value upward of $1,250 to the organization’s bottom line.
![Group of people putting hands in center](/sites/default/files/styles/tiered_sponsor/public/2024-04/Volunteer%20blog%20option%202.jpg?itok=qH_mxLdD)
Volunteers: The Engine Powering LLS’s Mission
I was always aware that volunteers with The Leukemia & Lymphoma Society (LLS) drive impact for blood cancer patients and families. But it wasn’t until Thanksgiving Day 2007 that I discovered the full force of their power. My wife, Holly, had recently been diagnosed with follicular lymphoma and our family was still reeling from the news. She was feeling quite ill, and we were exhausted with worry and trying to keep life as normal as possible for our two young children.
The First Official Day of #ASH15
Beat AML is a collaboration launched nearly three years ago by LLS and the Knight Cancer Institute at Oregon Health & Science University (OHSU), to go on the offenensive against acute myeloid leukemia (AML), a blood cancer with a poor prognosis and little change in the standard of care in 40 years. More than a dozen abstracts from the first phase of the initiative will be featured throughout the American Society of Hematology (#ASH15) Annual Meeting in Orlando over the next few days.
Epigenetics: A New Tool for Precision Medicine
Christopher Vakoc, M.D., Ph.D., leads a team of researchers being funded through LLS’s Career Development Program. At Cold Spring Harbor Laboratory in Long Island, N.Y., Vakoc works in an area of science called epigenetics – the study of chemical changes that switch genes on and off to control cell behavior.
What is epigenetics?
Epigenetics is arguably one of the fastest-moving fields of cancer research.
High Hopes: How a Rising Star Basketball Player’s Story is Bringing Light to the Darkness of Cancer
Each year, from September to November, thousands of illuminated lanterns light up the sky across the country as part of The Leukemia & Lymphoma Society’s Light The Night fundraising campaign – all to end cancer. For one rising star basketball player and Light The Night Honored Hero, Maurice Smith, taking steps to end cancer gave him, and so many others, high hopes for a brighter future.
4 Things Cancer Patients Need to Know about the Coronavirus
The Leukemia & Lymphoma Society is closely monitoring the coronavirus (COVID-19) outbreak that originated in China and is spreading to other countries around the globe. As a health organization, one of our highest priorities is the well-being of the patients we serve – especially as many blood cancer patients are immunocompromised.
#ASH18: Update on Immunotherapy
Immunotherapy – harnessing the body’s immune system to fight disease – is rapidly becoming a mainstay of cancer treatment. The increasing interest in this field was clear at yesterday’s standing-room only symposium hosted by The Leukemia & Lymphoma Society in advance of the 60th ASH (American Society of Hematology) Meeting which officially kicks off today here in San Diego. Over the next few days more than 30,000 researchers and others connected to the blood cancers and other blood malignancies will gather to hear the latest data from clinical trials.
CEO Who Lost Mom to Leukemia Works to Advance Cures
A month after Dr. Matt McManus of Austin, Texas, lost his mother to leukemia, he joined LLS as the 2016 Austin Light The Night Corporate Walk Chair. In her honor, he is helping to fund research to find cures and ensure access to treatments for blood cancer patients.
Reflecting on a Year of Accomplishments and Looking Forward to 2017
LLS President and CEO Louis J. DeGennaro shares his optimism about LLS’s role and promise for patients.
Celebrating Our Amazing Volunteers This National Intern Day
I can’t think of better partners to join us in the fight against cancer than the future nonprofit and healthcare executives of the world. Whether students, recent grads or professionals transitioning to a new career path, LLS embraces the support of volunteer interns throughout the year as we work tirelessly toward a world without blood cancer.
Ask the Doctor Part 2: Five Questions about Lymphoma
Lymphoma survivor, Jessica Melore talks to Dr. Nichols about the Latest in Lymphoma Research and Treatment
#ASH16 (Blog 1): Is the Best Yet to Come in Immunotherapy?
This is the first of a series of blogs covering the 58th ASH Annual Meeting and Exposition in San Diego (#ASH16) conference over the next few days. Check back for more news from the meeting.
Eating Well During Cancer Treatment
Making healthy food choices before, during, and after cancer treatment can help you feel better and stay stronger. In fact, people living with cancer who eat well and keep or achieve a healthy weight usually manage treatment side effects better. Eating well also helps the body replace blood cells and healthy tissues that may be damaged as a result of treatment.
Ultra-Endurance Athlete Takes on 1000-Mile Iconic Race for Cancer Cures
52-year-old Steve Cannon from Iowa refers to himself as an adventurer, but when you look at his track record of accomplishments, media, spectators and fans across the country refer to him as a beast. He was the first-ever athlete to run around Lake Michigan and averaged a marathon a day for 40 straight days totaling 1,037 miles. He’s also completed a 350-mile bike ride and took on the world’s longest Kayak race – just to list a few.
Five Reasons to Give Thanks
The Leukemia & Lymphoma Society (LLS) exists to find cures for blood cancers and improve the quality of life of patients and their families. The fervor with which experts, patients and supporters rally around this cause is impressive and it’s only because of that synergy that we’re able to make such significant progress in saving lives.
In the spirit of Thanksgiving, we wanted to share five reasons we are giving thanks this holiday season.
The Fruits of Our Funding
Advances in cancer research seem to be occurring at dizzying speed these days.